2022MWI 1320x300

In This Section

10/26: CONCURRENT SESSION: Prescription Drug Importation, Legal Limits and Remedies

October 26, 2020 9:00 AM to 10:30 AM

Location

Virtual - all times are eastern daylight time

Credits

90 CLE Minutes


 

Topic:

CONCURRENT SESSION: Prescription Drug Importation, Legal Limits and Remedies 



Moderator

Alison Kessler, LifeSci Consulting, LLC 

Speakers:

Sara Koblitz, Hyman Phelps & McNamara, Washington, DC, 
Monisha Deka, US International Trade Commission, Washington, DC
Jennifer Dienes, US International Trade Commission, Washington, DC
Craig Svoboda, Alvotech USA Inc., Arlington, VA



A joint program of the Food & Drug, IP Transactions, ITC, and Biotechnology Committees

Speakers

  • Dienes, Jennifer 200 Dienes, Jennifer

    US International Trade Commission | Investigative Attorney

    Jennifer Dienes has been an Investigative Attorney at the US International Trade Commission (ITC) in Washington DC for 1 year. Investigative attorneys advocate on behalf of the public interest in intellectual property investigations initiated under 19 U.S.C. 1337, commonly referred to as Section 337 litigations.
  • Deka, Monisha Deka, Monisha

    US International Trade Commission | Investigative Attorney

    Monisha Deka (Mo) has been an Investigative Attorney at the US International Trade Commission (ITC) in Washington DC for almost 8 years. Investigative attorneys advocate on behalf of the public interest in intellectual property investigations initiated under 19 U.S.C. 1337, commonly referred to as Section 337 litigations.
  • Svoboda, C Svoboda, Craig

    Alvotech | Global Head Intellectual Property

    Craig Svoboda has extensive experience with patents and intellectual property in the pharmaceutical industry. He has served as in-house counsel for innovator small molecule and biologics and most recently with the biosimilar company Alvotech. Craig’s skills includes patent drafting, prosecution and portfolio management; client advising including patentability, freedom to operate, non-infringement and validity opinions; licensing including IP diligence, contract drafting and negotiations. Craig’s former and current roles include strategic counseling and creative applications of providing legal advice to efficiently and effectively influence fast moving product development.
  • Kessler, Allison (2)200 Kessler, Alison

    LifeSci Consulting

    Alison Kessler is Principal Member and Founder of LifeSci Consulting LLC, where she guides Life Sciences companies through decision-making processes on matters ranging from strategy, intellectual property, and business development. With over 20 years’ experience, Alison has served as General Counsel at Cosette Pharmaceuticals; Vice President, Global Head of Intellectual Property at ConvaTec; Global Head of Patents at Novartis Consumer Health; and US Head of IP, Business Development & Licensing at Sandoz. Alison began her legal career at Goodwin Procter LLP focusing on IP matters in both the corporate and litigation groups.
  • Koblitz, Sara200 Koblitz, Sara W.

    Hyman, Phelps & McNamara | Associate

    Sara W. Koblitz advises FDA-regulated clients on a range of issues with a particular focus on Hatch-Waxman patent and exclusivity, biosimilars, and the Orange Book. She helps drug and device manufacturers in various stages of product development and guides clients through the applicable regulatory requirements with respect to applications and submissions, device classification, potential exclusivities, promotional issues, and post-marketing requirements.